Inspire Medical Systems, Inc. logo

Inspire Medical Systems, Inc. (INSP)

Market Closed
1 Sep, 20:00
NYSE NYSE
$
61. 52
-1.47
-2.3337%
$
1.78B Market Cap
- P/E Ratio
- Div Yield
351,708 Volume
-1.18 Eps
$ 62.99
Previous Close
Add Transaction
Day Range
61.2 63.31
Year Range
38.91 147.03
Want to track INSP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
INSP vs. HIMS: Which Stock Should Value Investors Buy Now?

INSP vs. HIMS: Which Stock Should Value Investors Buy Now?

Investors interested in Medical Info Systems stocks are likely familiar with Inspire Medical Systems (INSP) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 5 months ago
Inspire Medical Systems, Inc. (INSP) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript

Inspire Medical Systems, Inc. (INSP) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript

Inspire Medical Systems, Inc. (INSP) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript

Seekingalpha | 5 months ago
Bamco Inc. NY Has $14.10 Million Stock Holdings in Inspire Medical Systems, Inc. $INSP

Bamco Inc. NY Has $14.10 Million Stock Holdings in Inspire Medical Systems, Inc. $INSP

Bamco Inc. NY decreased its holdings in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by 61.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 190,023 shares of the company's stock after selling 301,729 shares during the quarter.

Defenseworld | 5 months ago
Why Is Inspire (INSP) Down 2.4% Since Last Earnings Report?

Why Is Inspire (INSP) Down 2.4% Since Last Earnings Report?

Inspire (INSP) reported earnings 30 days ago. What's next for the stock?

Zacks | 5 months ago
Here's Why You Should Retain INSP Stock in Your Portfolio for Now

Here's Why You Should Retain INSP Stock in Your Portfolio for Now

Inspire Medical continues to grow on strong Q4 results and continued R&D investments as the company advances its sleep apnea therapy.

Zacks | 6 months ago
Inspire Medical: Still A Long Way From A Good Night's Sleep

Inspire Medical: Still A Long Way From A Good Night's Sleep

Inspire Medical Systems faces intensifying competition, reimbursement headwinds, and decelerating growth in the obstructive sleep apnea device market. Despite Q4 revenue and EPS beats, FY26 guidance implies just 4–10% revenue growth, higher capex, and a projected net loss amid operational challenges. Valuation remains stretched even after a 66% stock decline; DCF analysis suggests current pricing bakes in optimistic growth and margin assumptions.

Seekingalpha | 6 months ago
INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands

INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands

INSP beats Q4 estimates with EPS up 43% and wider margins, but shares tumble 8.7% after a lower 2026 revenue outlook.

Zacks | 6 months ago
Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript

Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript

Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript

Seekingalpha | 6 months ago
Inspire Medical Systems (INSP) Beats Q4 Earnings and Revenue Estimates

Inspire Medical Systems (INSP) Beats Q4 Earnings and Revenue Estimates

Inspire Medical Systems (INSP) came out with quarterly earnings of $1.65 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $1.15 per share a year ago.

Zacks | 6 months ago
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy?

Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy?

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 6 months ago
Here's Why You Should Retain INSP Stock in Your Portfolio for Now

Here's Why You Should Retain INSP Stock in Your Portfolio for Now

INSP navigates a product shift as Inspire V gains traction, reimbursement improves, and management balances growth with near-term pressures.

Zacks | 7 months ago
Inspire Medical Systems, Inc. (INSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Inspire Medical Systems, Inc. (INSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Inspire Medical Systems, Inc. (INSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 7 months ago
Loading...
Load More